Inventor · disambiguated record
Dennis R. Burton
Also filed as: BURTON DENNIS · BURTON DENNIS R · BURTON DENNIS RAYMOND
55 granted patents·25 pending applications·8,607 citations·filing 1993–2025
99Inventor score
Files withSCRIPPS RESEARCH INST37THERACLONE SCIENCES INC12INT AIDS VACCINE INITIATIVE8UNIV CALIFORNIA5BURTON DENNIS R3
Top patents by PatentIndex Score
80 records- 0198US6562341B2Antibodies specific for native PrPScUNIV CALIFORNIA·Filed 2001·Granted May 13, 2003·86 cites·5 claims
- 0298US5648260ADNA encoding antibodies with altered effector functionsSCOTGEN BIOPHARMACEUTICALS INC·Filed 1995·Granted Jul 15, 1997·3.4k cites·30 claims
- 0398US5624821AAntibodies with altered effector functionsSCOTGEN BIOPHARMACEUTICALS INC·Filed 1995·Granted Apr 29, 1997·3.8k cites·25 claims
- 0497US6096551AMethods for producing antibody libraries using universal or randomized immunoglobulin light chainsSCRIPPS RESEARCH INST·Filed 1997·Granted Aug 1, 2000·187 cites·7 claims
- 0597US5846533AAntibodies specific for native PrPScUNIV CALIFORNIA·Filed 1996·Granted Dec 8, 1998·145 cites·11 claims
- 0697US5667988AMethods for producing antibody libraries using universal or randomized immunoglobulin light chainsSCRIPPS RESEARCH INST·Filed 1994·Granted Sep 16, 1997·257 cites·3 claims
- 0796US12410243B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesINT AIDS VACCINE INITIATIVE INC·Filed 2023·Granted Sep 9, 2025·2 cites·16 claims
- 0896US10087239B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2016·Granted Oct 2, 2018·14 cites·7 claims
- 0995US9464131B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2013·Granted Oct 11, 2016·18 cites·4 claims
- 1095US7067284B1Methods for producing antibody libraries using universal or randomized immunoglobulin light chainsSCRIPPS RESEARCH INST·Filed 2000·Granted Jun 27, 2006·59 cites·19 claims
- 1194US5804440AHuman neutralizing monoclonal antibodies to human immunodeficiency virusSCRIPPS RESEARCH INST·Filed 1997·Granted Sep 8, 1998·113 cites·8 claims
- 1294US5762905AHuman neutralizing monoclonal antibodies to respiratory syncytial virusSCRIPPS RESEARCH INST·Filed 1993·Granted Jun 9, 1998·112 cites·29 claims
- 1393USRE50268EBroadly neutralizing antibody and uses thereofINT AIDS VACCINE INITIATIVE·Filed 2022·Granted Jan 14, 2025·2 cites·30 claims
- 1493US10093720B2Broadly neutralizing antibody and uses thereofINT AIDS VACCINE INITIATIVE·Filed 2015·Granted Oct 9, 2018·12 cites·6 claims
- 1592US9051362B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityCHAN-HUI PO-YING·Filed 2010·Granted Jun 9, 2015·14 cites·20 claims
- 1691US12312396B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2024·Granted May 27, 2025·0 cites·32 claims
- 1791US11319362B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesTHERACLONE SCIENCES INC·Filed 2019·Granted May 3, 2022·3 cites·44 claims
- 1891US6372214B1Antibodies specific for native PrPScUNIV CALIFORNIA·Filed 2000·Granted Apr 16, 2002·30 cites·12 claims
- 1990US7364737B2Human neutralizing monoclonal antibodies to respiratory syncytial virusSCRIPPS RESEARCH INST·Filed 2004·Granted Apr 29, 2008·18 cites·16 claims
- 2090US6685942B1Human neutralizing monoclonal antibodies to respiratory syncytial virusSCRIPPS RESEARCH INST·Filed 1997·Granted Feb 3, 2004·64 cites·16 claims
- 2188US5652138AHuman neutralizing monoclonal antibodies to human immunodeficiency virusSCRIPPS RESEARCH INST·Filed 1994·Granted Jul 29, 1997·60 cites·3 claims
- 2287USRE49037EBroadly neutralizing antibody and uses thereofINT AIDS VACCINE INITIATIVE·Filed 2019·Granted Apr 19, 2022·3 cites·23 claims
- 2387US6537548B1Antibodies specific for ungulate PrPUNIV CALIFORNIA·Filed 2000·Granted Mar 25, 2003·11 cites·8 claims
- 2486US12018067B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2023·Granted Jun 25, 2024·0 cites·29 claims
- 2585US10865234B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2019·Granted Dec 15, 2020·1 cites·7 claims
- 2685US2025122247A1Compositions and methods related to hiv-1 immunogensSCRIPPS RESEARCH INST·Filed 2024·Application pending·0 cites
- 2783US11795211B2Rapid elicitation of broadly neutralizing antibodies to HIV EnvINT AIDS VACCINE INITIATIVE·Filed 2018·Granted Oct 24, 2023·3 cites·13 claims
- 2883US10836811B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2017·Granted Nov 17, 2020·1 cites·4 claims
- 2983US6156313AHuman monoclonal antibodies to herpes simplex virus and methods thereforSCRIPPS RESEARCH INST·Filed 1997·Granted Dec 5, 2000·68 cites·8 claims
- 3082US6261558B1Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virusSCRIPPS RESEARCH INST·Filed 1994·Granted Jul 17, 2001·41 cites·40 claims
- 3182US2024083954A1Compositions and methods related to hiv-1 immunogensSCRIPPS RESEARCH INST·Filed 2023·Application pending·0 cites
- 3281US10407493B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2019·Granted Sep 10, 2019·1 cites·20 claims
- 3380US7223844B2Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by Env-CD4-co-receptor complexesSCRIPPS RESEARCH INST·Filed 2002·Granted May 29, 2007·16 cites·27 claims
- 3479US11845789B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesTHERACLONE SCIENCES INC·Filed 2021·Granted Dec 19, 2023·0 cites·15 claims
- 3579US7060799B2Antibody for ligand capture assaySCRIPPS RESEARCH INST·Filed 2002·Granted Jun 13, 2006·4 cites·4 claims
- 3678US7378093B2Broadly cross-reactive neutralizing antibodies against Human Immunodeficiency Virus selected by Env-CD4-co-receptor complexesUS HEALTH·Filed 2007·Granted May 27, 2008·3 cites·15 claims
- 3778US2025320281A1Methods of treating hiv-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (hiv-1) gp120-specific monoclonal antibodiesINT AIDS VACCINE INITIATIVE INC·Filed 2025·Application pending·0 cites
- 3877US11767347B2HIV-1 GP140 immunogens comprising modified NHR1 regions that stabilize pre-fusion envelope conformationsSCRIPPS RESEARCH INST·Filed 2021·Granted Sep 26, 2023·0 cites·21 claims
- 3977US6290954B1Antibodies specific for native PrPScSCRIPPS RESEARCH INST·Filed 1998·Granted Sep 18, 2001·29 cites·9 claims
- 4076US11584789B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2020·Granted Feb 21, 2023·0 cites·31 claims
- 4176US7662644B2Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparationSCRIPPS RESEARCH INST·Filed 2007·Granted Feb 16, 2010·2 cites·18 claims
- 4276US6376170B1Ligand capture-directed selection of antibodySCRIPPS RESEARCH INST·Filed 1997·Granted Apr 23, 2002·26 cites·9 claims
- 4375US7176037B2Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparationSCRIPPS RESEARCH INST·Filed 2003·Granted Feb 13, 2007·4 cites·6 claims
- 4474US7473424B2Anti-dengue virus antibodies and compositionsSCRIPPS RESEARCH INST·Filed 2004·Granted Jan 6, 2009·10 cites·5 claims
- 4571US11236134B2Nucleic acids encoding HIV-1 GP140 immunogens comprising modified NHR1 regions that stabilize pre-fusion conformationsSCRIPPS RESEARCH INST·Filed 2020·Granted Feb 1, 2022·0 cites·18 claims
- 4671US10647748B2HIV-1 GP140 immunogens comprising modified NHR1 regions that stabilize pre-fusion conformationsSCRIPPS RESEARCH INST·Filed 2018·Granted May 12, 2020·0 cites·18 claims
- 4770US7052675B2Antibodies specific for native PrPScSCRIPPS RESEARCH INST·Filed 2004·Granted May 30, 2006·0 cites·7 claims
- 4869US10239934B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2018·Granted Mar 26, 2019·0 cites·14 claims
- 4969US2024109956A1Rapid elicitation of broadly neutralizing bovine antibodies to hiv envINT AIDS VACCINE INITIATIVE·Filed 2023·Application pending·0 cites
- 5067US12398177B2SIV envelope trimerSCRIPPS RESEARCH INST·Filed 2021·Granted Aug 26, 2025·0 cites·18 claims
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dennis R. Burton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →